| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.055 | 0.4 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |